A 6-Month Extension Study of VMDN-003-2 to Assess Engensis in Participants With Painful Diabetic Peripheral Neuropathy
Public ClinicalTrials.gov record NCT04873232. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 6-Month Extension Study Following Protocol VMDN-003-2 - An Adaptive, Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess Engensis in Participants With Painful Diabetic Peripheral Neuropathy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To evaluate the durability of efficacy and long-term safety of intramuscular administration of Engensis or Placebo that was administered in the double-blind, randomized, VMDN-003-2 Placebo-controlled Phase 3 Study.
Study identification
- NCT ID
- NCT04873232
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 106 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 17, 2021 (Actual)
- Primary completion
- Sep 14, 2023 (Actual)
- Completion
- Jul 23, 2024 (Actual)
- Last update posted
- Oct 9, 2025
2021 – 2024
United States locations
- U.S. sites
- 16
- U.S. states
- 10
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arizona Research Center | Phoenix | Arizona | 85053 | — |
| Clinical Trials - Little Rock | Little Rock | Arkansas | 72205 | — |
| California Medical Clinic for Headache | Los Angeles | California | 90048 | — |
| Clinical Trials Research - Sacramento | Sacramento | California | 95821 | — |
| Innovative Research of West Florida, Inc. | Clearwater | Florida | 33756 | — |
| Gateway Clinical Trials, LLC | O'Fallon | Illinois | 62269 | — |
| Foot & Ankle Center of Illinois | Springfield | Illinois | 62704 | — |
| Clinical Research Professionals | Chesterfield | Missouri | 63005 | — |
| Richmond Behavioral Associates | Staten Island | New York | 10314 | — |
| Health Concepts | Rapid City | South Dakota | 57702 | — |
| Nerve and Muscle Center of Texas | Houston | Texas | 77030 | — |
| Futuro Clinical Trials | McAllen | Texas | 78501 | — |
| ClinPoint Trials LLC | Waxahachie | Texas | 75165 | — |
| Manassas Clinical Research Center | Manassas | Virginia | 20110 | — |
| Eastern Virginia Medical School | Norfolk | Virginia | 23510 | — |
| Dominion Medical Associates | Richmond | Virginia | 23219 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04873232, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 9, 2025 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04873232 live on ClinicalTrials.gov.